1. Home
  2. ENHA vs VALN Comparison

ENHA vs VALN Comparison

Compare ENHA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enhanced Group Inc. Class A Common Stock

ENHA

Enhanced Group Inc. Class A Common Stock

N/A

Current Price

$1.57

Market Cap

632.1M

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.58

Market Cap

653.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENHA
VALN
Founded
N/A
2012
Country
Singapore
France
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.1M
653.3M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ENHA
VALN
Price
$1.57
$6.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
1.3M
81.9K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$4.75
52 Week High
$4.60
$12.23

Technical Indicators

Market Signals
Indicator
ENHA
VALN
Relative Strength Index (RSI) 30.19 57.83
Support Level $1.50 $5.10
Resistance Level $1.71 $7.31
Average True Range (ATR) 0.13 0.23
MACD 0.04 -0.05
Stochastic Oscillator 27.26 47.78

Price Performance

Historical Comparison
ENHA
VALN

About ENHA Enhanced Group Inc. Class A Common Stock

Enhanced Group Inc develops and sells sports and performance-related products intended for use by athletes and consumers. Its offerings focus on products associated with physical performance, health, and recovery. Its two principal offerings include: (i) the Enhanced Games, a live, multi-sport competition platform designed to showcase both "Enhanced" and "Non-Enhanced" athletes pursuing world-record performances under medically supervised conditions; and (ii) Live Enhanced, a direct-to-consumer digital and clinician-guided wellness platform offering evidence-based protocols, supplements, and coaching for consumers seeking to improve health, longevity, and well-being. The majority of the company's revenue is derived from products associated with physical performance, health, and recovery.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: